Estrogen receptor-positive, her2-negative locally advanced or metastatic breast cancer Clinical Trials

Delta Trials indexes 2 clinical trials for Estrogen receptor-positive, her2-negative locally advanced or metastatic breast cancer in its publicly accessible dataset. Of these, 0 enrolling participants at this time and 0 trials have reached completion. This research takes place spanning 249 research sites around the world. An additional 2 trials are in preparatory or other active non-recruiting stages. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.